Onconetix, Inc. Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination
Onconetix, Inc. (ONCO) reported Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination of $19.03 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree
us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1 · last filed 2023-11-17
- Onconetix, Inc. business combination, consideration transferred, including equity interest in acquiree held prior to combination for the quarter ending 2023-09-30 was $0.00.
| Period end | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 3 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 6 month | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $19.03M 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $19.03M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |